© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
July 01, 2022
The organization hopes to increase awareness and education of a condition that affects vision, mental health.
May 31, 2022
One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
April 05, 2022
Top-line results are expected during second quarter for the therapeutic to treat patients with dry eye disease.
February 25, 2022
TearSolutions Inc. is preparing to conduct two trials, one in a primary Sjögren’s Syndrome patient population and the second in a potentially less severe general dry eye population for the treatment of DED.
November 02, 2021
Aldeyra Therapeutics announced today that it has achieved the primary endpoint of ocular redness in its randomly assigned, double-masked, vehicle-controlled Phase 2 clinical trial in dry eye disease.
October 04, 2021
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
September 16, 2021
TearLab, MellingMedical reach an agreement to enhance early detection of dry eye disease in veterans.
August 23, 2021
According to the company, its partnership will educate the gaming community on common dry eye symptoms and introduce over-the-counter options like its Systane brand of eye drops.
August 10, 2021
The company is evaluating topical cyclosporine to treat the signs and symptoms of dry eye disease.